These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38485739)

  • 1. Purine salvage-associated metabolites as biomarkers for early diagnosis of esophageal squamous cell carcinoma: a diagnostic model-based study.
    Sun Y; Liu W; Su M; Zhang T; Li X; Liu W; Cai Y; Zhao D; Yang M; Zhu Z; Wang J; Yu J
    Cell Death Discov; 2024 Mar; 10(1):139. PubMed ID: 38485739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers.
    Zhu ZJ; Qi Z; Zhang J; Xue WH; Li LF; Shen ZB; Li ZY; Yuan YL; Wang WB; Zhao J
    J Cancer; 2020; 11(13):3944-3954. PubMed ID: 32328198
    [No Abstract]   [Full Text] [Related]  

  • 3. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma.
    Zhao J; Zhao X; Yu J; Gao S; Zhang M; Yang T; Liu L
    Anal Chim Acta; 2022 Aug; 1220():340038. PubMed ID: 35868700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untargeted metabolomics analysis of esophageal squamous cell cancer progression.
    Yang T; Hui R; Nouws J; Sauler M; Zeng T; Wu Q
    J Transl Med; 2022 Mar; 20(1):127. PubMed ID: 35287685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-based metabolomics reveals metabolic biomarkers and potential therapeutic targets for esophageal squamous cell carcinoma.
    Chen Z; Gao Y; Huang X; Yao Y; Chen K; Zeng S; Mao W
    J Pharm Biomed Anal; 2021 Apr; 197():113937. PubMed ID: 33609949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Metabolomic Analysis of Plasma and Tissue Reveals a Prognostic Risk Score System and Metabolic Dysregulation in Esophageal Squamous Cell Carcinoma.
    Chen Z; Dai Y; Huang X; Chen K; Gao Y; Li N; Wang D; Chen A; Yang Q; Hong Y; Zeng S; Mao W
    Front Oncol; 2020; 10():1545. PubMed ID: 32984013
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum proteomics unveil characteristic protein diagnostic biomarkers and signaling pathways in patients with esophageal squamous cell carcinoma.
    Liu W; Wang Q; Chang J; Bhetuwal A; Bhattarai N; Zhang F; Tang J
    Clin Proteomics; 2022 May; 19(1):18. PubMed ID: 35610567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma.
    Wang PP; Song X; Zhao XK; Wei MX; Gao SG; Zhou FY; Han XN; Xu RH; Wang R; Fan ZM; Ren JL; Li XM; Wang XZ; Yang MM; Hu JF; Zhong K; Lei LL; Li LY; Chen Y; Chen YJ; Ji JJ; Yang YZ; Li J; Wang LD
    Front Oncol; 2022; 12():790933. PubMed ID: 35155234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry.
    Zhang S; Lu X; Hu C; Li Y; Yang H; Yan H; Fan J; Xu G; Abnet CC; Qiao Y
    ACS Omega; 2020 Oct; 5(41):26402-26412. PubMed ID: 33110968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with the progression of gastroesophageal cancer.
    Che J; Zhao Y; Gu B; Li S; Li Y; Pan K; Sun T; Han X; Lv J; Zhang S; Fan B; Li C; Wang C; Wang J; Zhang T
    BMC Cancer; 2023 Dec; 23(1):1238. PubMed ID: 38102546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Metabolic Alterations and A Predictive Marker Pipecolic Acid in Sera for Esophageal Squamous Cell Carcinoma.
    Liu L; Wu J; Shi M; Wang F; Lu H; Liu J; Chen W; Yu G; Liu D; Yang J; Luo Q; Ni Y; Jin X; Jin X; Chen WL
    Genomics Proteomics Bioinformatics; 2022 Aug; 20(4):670-687. PubMed ID: 35351627
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Ouyang T; Ma C; Zhao Y; Ye W; Zhao J; Cai R; Zhang H; Zheng P; Lin Y
    Front Oncol; 2023; 13():1082841. PubMed ID: 36756157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
    Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
    Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.
    Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z
    Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
    Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
    Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring potential biomarkers of early stage esophageal squamous cell carcinoma in pre- and post-operative serum metabolomic fingerprint spectrum using
    Yang Z; Liu Y; Ma L; Wen X; Ji H; Li K
    Am J Transl Res; 2019; 11(2):819-831. PubMed ID: 30899382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
    Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
    Front Oncol; 2021; 11():769727. PubMed ID: 34926275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma.
    Luo Y; Hong CQ; Huang BL; Ding TY; Chu LY; Zhang B; Qu QQ; Li XH; Liu CT; Peng YH; Guo HP; Xu YW
    Ann Med; 2022 Dec; 54(1):2153-2166. PubMed ID: 35930383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of serum cystatin SN detection for diagnosis and poor prognosis of esophageal squamous cell carcinoma.
    Pi Y; Lin S; Ren X; Wang L; Song Y; Wu Z; Lai Y
    Front Oncol; 2024; 14():1337707. PubMed ID: 38414741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A RASSF8-AS1 based exosomal lncRNAs panel used for diagnostic and prognostic biomarkers for esophageal squamous cell carcinoma.
    Xie K; Zheng C; Gu W; Jiang Z; Luo C; Luo J; Diao Y; Wang G; Cong Z; Yao X; Hu L; Shen Y
    Thorac Cancer; 2022 Dec; 13(23):3341-3352. PubMed ID: 36266257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.